Principal Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
|
|||||
|
2025
Q1 | $1.24M | Sell |
|
|||||
|
2024
Q4 | $2.04M | Buy |
|
|||||
|
2024
Q3 | $1.62M | Sell |
|
|||||
|
2024
Q2 | $1.75M | Sell |
|
|||||
|
2024
Q1 | $1.63M | Sell |
|
|||||
|
2023
Q4 | $1.25M | Sell |
|
|||||
|
2023
Q3 | $1.3M | Sell |
|
|||||
|
2023
Q2 | $1.05M | Buy |
|
|||||
|
2023
Q1 | $979K | Sell |
|
|||||
|
2022
Q4 | $1.03M | Buy |
|
|||||
|
2022
Q3 | $875K | Sell |
|
|||||
|
2022
Q2 | $1.01M | Sell |
|
|||||
|
2022
Q1 | $1.31M | Buy |
|
|||||
|
2021
Q4 | $1.09M | Sell |
|
|||||
|
2021
Q3 | $1.5M | Buy |
|
|||||
|
2021
Q2 | $1.5M | Buy |
|
|||||
|
2021
Q1 | $1.49M | Buy |
|
|||||
|
2020
Q4 | $1.15M | Sell |
|
|||||
|
2020
Q3 | $1.19M | Sell |
|
|||||
|
2020
Q2 | $1.84M | Sell |
|
|||||
|
2020
Q1 | $1.35M | Buy |
|
|||||
|
2019
Q4 | $1.22M | Buy |
|
|||||
|
2019
Q3 | $599K | Sell |
|
|||||
|
2019
Q2 | $1.22M | Sell |
|
|||||
|
2019
Q1 | $46.8M | Buy |
|
|||||
|
2018
Q4 | $40.1M | Buy |
|
|||||
|
2018
Q3 | $19.6M | Buy |
|
|||||
|
2018
Q2 | $2.78M | Buy |
|
|||||
|
2018
Q1 | $1.9M | Sell |
|
|||||
|
2017
Q4 | $2.12M | Sell |
|
|||||
|
2017
Q3 | $2.1M | Sell |
|
|||||
|
2017
Q2 | $4.13M | Buy |
|
|||||
|
2017
Q1 | $3.29M | Sell |
|
|||||
|
2016
Q4 | $3.95M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $34.5M | Sell |
|
|||||
|
2016
Q1 | $96.5M | Buy |
|
|||||
|
2015
Q4 | $118M | Buy |
|
|||||
|
2015
Q3 | $92.2M | Buy |
|
|||||
|
2015
Q2 | $41.4M | Buy |
|
|||||
|
2015
Q1 | $43.4M | Buy |
|
|||||
|
2014
Q4 | $12M | Buy |
|
|||||
|
2014
Q3 | $9.77M | Buy |
|